References
- J.W. Bae, M.J. Kim, C.G. Jung and S.Y. Lee, Determination of meloxicam in human plasma using a HPLC method with UV detection and its application to a pharmacokinetic study, J. Chromatogr. B., 859, 69-73 (2007). https://doi.org/10.1016/j.jchromb.2007.09.004
- J.L. Wiesner, A.D. de Jager, F.C.W. Sutherland, H.K.L. Hundt, K.J. Swart and A.F. Hundt, Sensitive and rapid liquid chromatography-tandem mass spectrometry method for the determination of meloxicam in human plasma, J. Chromatogr. B., 785, 115-121 (2003). https://doi.org/10.1016/S1570-0232(02)00862-0
- G. Marcelin-Jimenez, Jose A. Hernandez, Alionka P. Angeles, L. Contreras, A. Garcia, M. Hinojosa, M. Morales, L. Rivera, L. Martinez-Rossier and A. Fernandez, Bioequivalence evaluation of two brands meloxicam tablets(Promotion and Mobicox): Pharmacokinetics in a healthy female mexican population, Biopharm. Drug Dispos., 26, 167-171 (2005). https://doi.org/10.1002/bdd.446
- J. Schmid, U. Busch, G. Heinzel, G. Bozler, S. Kaschke and M. Kummer, Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects, Drug Metab. Dispos., 23, 1206-1213 (1995).
-
Y.R. Lee, S.B. Yeom, Y.J. Ko, J.K. Ko, H. Kim, H.J. Lee and K.R. Lee, Bioequivalence of Mela
$x^{TM}$ Capsule to Mobi$c^{TM}$ Capsule (Meloxicam 7.5 mg), J. Kor. Pharm. Sci., 34 (5), 413-418 (2004) - 식품의약품안전청 고시 제 2009-67호(2009. 8. 18), 생물학적 동등성시험기준
- 식품의약품안전청 고시 제 1999-67호(2000. 1. 4), 의약품임상시험관리기준